Leukemia

Stimulation of dendritic cell maturation and induction of apoptosis in lymphoma cells by a stable lectin from buckwheat seeds

C. Z. Bai, Ji, H. J., Feng, M. L., Hao, X. L., Zhong, Q. M., Cui, X. D., and Wang, Z. H., Stimulation of dendritic cell maturation and induction of apoptosis in lymphoma cells by a stable lectin from buckwheat seeds, vol. 14, pp. 2162-2175, 2015.

The present study aims to purify and characterize lectin from tartary buckwheat seeds and study its properties as well as biological activities to determine its possible biomedical applications in promoting maturation and proliferation of peripheral blood DCs derived from healthy donors and to study the effect of inducing apoptosis in human leukemia U937 cells. A novel tartary buckwheat lectin (TBL) protein, purified from tartary buckwheat seeds, showed a single band with a molecular mass of 65 kDa in SDS-PAGE.

Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis

Y. Zhao, He, H. R., Wang, M. Y., Ren, X. D., Zhang, L., Dong, Y. L., and Lu, J., Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis, vol. 14, pp. 5171-5180, 2015.

Cyclin D1 (CCND1) is a key protein involved in cell-cycle regulation, and the CCND1 G870A polymorphism is associated with many types of malignancy. Studies examining the associations between this G870A polymorphism and susceptibility to leukemia and hepatocellular carcinoma (HCC) have shown inconsistent results. Therefore, we conducted a meta-analysis to clarify these associations. A search of the PubMed database yielded 7 relevant articles: 3 pertaining to leukemia and 4 to HCC. The odds ratios (ORs) from individual studies were pooled using a fixed or random-effect model.

Prediction and extraction of microRNA2target interactions associated with leukemia

L. Gong, Yan, Q., Yang, R., and Sun, X., Prediction and extraction of microRNA2target interactions associated with leukemia, vol. 13, pp. 2120-2129, 2014.

MicroRNAs are small, non-coding RNAs that regulate gene expression by suppressing mRNA translation or inducing mRNA degradation, and have been implicated in a growing number of diseases. To understand microRNAs’ function, it is vital to identify microRNA2target interactions. This work explores the prediction and extraction of leukemia-associated microRNA2target interactions, based on text mining. We extracted 371 interactions of microRNA2targets that, from prior knowledge, could be related to leukemia.

Identification of differently expressed genes in leukemia using multiple microarray datasets

Z. Y. Zhang, Xu, R. Q., Guo, T. J., Zhang, M., Li, D. X., and Lu, X. Y., Identification of differently expressed genes in leukemia using multiple microarray datasets, vol. 13, pp. 10482-10489, 2014.

The purpose of this study was to identify differentially expressed genes and analyze biological processes related to leukemia. A meta-analysis was performed using the Rank Product package of Gene Expression Omnibus datasets for leukemia. Next, Gene Ontology-enrichment analysis and pathway analysis were performed using the Gene Ontology website and Kyoto Encyclopedia of Genes and Genomes. A protein-protein interaction network was constructed using the Cytoscape software.

The role of α-satellite DNA and heterochromatin polymorphism in leukemia patients and illicit drug addicts

A. Movafagh, Mortazavi-Tabatabaei, S. A., and Kolahi, A. A., The role of α-satellite DNA and heterochromatin polymorphism in leukemia patients and illicit drug addicts, vol. 10, pp. 3999-4005, 2011.

Heterochromatin is considered to play a role in protecting the genome against mutagens. Changes in the quantity and proportion of different types of satellite DNA could increase genetic susceptibility in individuals with heterochromatic variations; they cause chromosome instability and predispose patients to malignancies. We evaluated the heterochromatin associated with chromosomes in 50 leukemia patients, 93 drug addicts and 93 healthy controls from Tehran, Iran.

ABO genotyping in leukemia patients reveals new ABO variant alleles

M. C. Z. Novaretti, Domingues, A. E., Manhani, R., Pinto, E. M., Dorlhiac-Llacer, P. E., and Chamone, D. A. F., ABO genotyping in leukemia patients reveals new ABO variant alleles, vol. 7, pp. 87-94, 2008.

The ABO blood group is the most important blood group system in transfusion medicine and organ transplantation. To date, more than 160 ABO alleles have been identified by molecular investigation. Almost all ABO genotyping studies have been performed in blood donors and families and for investigation of ABO subgroups detected serologically. The aim of the present study was to perform ABO genotyping in patients with leukemia.

Leukemia/lymphoma-associated gene fusions in normal individuals

M. S. Brassesco, Leukemia/lymphoma-associated gene fusions in normal individuals, vol. 7. pp. 782-790, 2008.

Hematopoietic neoplasias are characterized by recurrent chromosomal aberrations that result in the formation of gene fusions and the subsequent expression of chimeric proteins with unique properties. However, in recent years, different lymphoma/leukemia-associated rearrangements, such as BCR/ABL, IGH/BCL2, ETV6/RUNX1 and MLL duplications, have been detected in healthy individuals. The presence of these rearrangements indicates that such translocations can be generated in normal hematopoietic cells without apparent oncogenic consequences.

Subscribe to Leukemia